What is JRF Ortho?
Founded in 2006, JRF Ortho operates at the intersection of surgical innovation and regenerative medicine. The company specializes in providing orthopedic surgeons with high-quality, viable cartilage solutions, including osteochondral allografts, meniscal allografts, and specialized tendons for ligament reconstruction. By focusing on the biomechanics and functionality of joints, JRF Ortho has established itself as a critical partner for clinicians aiming to improve patient quality of life. Their market position is defined by a rigorous commitment to superior clinical outcomes and a collaborative approach with scientists and surgeons to push the boundaries of sports medicine.
How much funding has JRF Ortho raised?
JRF Ortho has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in JRF Ortho
PPP
Public-Private Partnership
What's next for JRF Ortho?
With this latest round of financing, JRF Ortho is well-positioned to scale its operational capabilities and expand its reach within the global orthopedic market. The company is expected to leverage this capital to accelerate research and development initiatives, potentially broadening its portfolio of allograft solutions. As the demand for minimally invasive joint restoration continues to rise, JRF Ortho's strategic focus on innovation will likely serve as a catalyst for sustained growth. The firm remains dedicated to refining its supply chain and clinical support infrastructure, ensuring that surgeons have access to the most advanced biological materials available for complex reconstructive procedures.
See full JRF Ortho company page
